Fandi A - Search Results

1

Phase II trial combining mitomycin with 5-fluorouracil, epirubicin, and cisplatin in recurrent and metastatic undifferentiated carcinoma of nasopharyngeal type.

Hasbini A, Mahjoubi R, Fandi A, Chouaki N, Taamma A, Lianes P, Cortès-Funes H, Alonso S, Armand JP, Cvitkovic E, Raymond E. Hasbini A, et al. Among authors: fandi a. Ann Oncol. 1999 Apr;10(4):421-5. doi: 10.1023/a:1008342828496. Ann Oncol. 1999. PMID: 10370784 Free article. Clinical Trial.

2

Biology and treatment of nasopharyngeal cancer.

Fandi A, Cvitkovic E. Fandi A, et al. Curr Opin Oncol. 1995 May;7(3):255-63. doi: 10.1097/00001622-199505000-00011. Curr Opin Oncol. 1995. PMID: 7654828 Review.

3

[Undifferentiated carcinoma of the nasopharynx: epidemiological, clinical and therapeutic aspects].

Fandi A, Yanes B, Taamma A, Azli N, Armand JP, Dupuis O, Eschwège F, Schwaab G, Cvitkovic E. Fandi A, et al. Bull Cancer. 1994 Jul;81(7):571-86. Bull Cancer. 1994. PMID: 7742599 Review. French.

4

Nasopharyngeal cancer: epidemiology, staging, and treatment.

Fandi A, Altun M, Azli N, Armand JP, Cvitkovic E. Fandi A, et al. Semin Oncol. 1994 Jun;21(3):382-97. Semin Oncol. 1994. PMID: 8209270 Review. No abstract available.

5

Palliative treatment with low-dose continuous infusion 5-fluorouracil in recurrent and/or metastatic undifferentiated nasopharyngeal carcinoma type.

Fandi A, Taamma A, Azli N, Bachouchi M, Yanes B, Armand JP, Cvitkovic E. Fandi A, et al. Head Neck. 1997 Jan;19(1):41-7. doi: 10.1002/(sici)1097-0347(199701)19:1<41::aid-hed8>3.0.co;2-v. Head Neck. 1997. PMID: 9030944 Clinical Trial.

6

Final report of a phase II study of chemotherapy with bleomycin, epirubicin, and cisplatin for locally advanced and metastatic/recurrent undifferentiated carcinoma of the nasopharyngeal type.

Azli N, Fandi A, Bachouchi M, Rahal M, Lianes P, Wibault P, Boussen H, Eschwege F, Armand JP, Cvitkovic E. Azli N, et al. Among authors: fandi a. Cancer J Sci Am. 1995 Sep-Oct;1(3):222-9. Cancer J Sci Am. 1995. PMID: 9166480 Clinical Trial.

7

Effective treatment of advanced biliary tract carcinoma using 5-fluorouracil continuous infusion with cisplatin.

Ducreux M, Rougier P, Fandi A, Clavero-Fabri MC, Villing AL, Fassone F, Fandi L, Zarba J, Armand JP. Ducreux M, et al. Among authors: fandi a, fandi l. Ann Oncol. 1998 Jun;9(6):653-6. doi: 10.1023/a:1008241008379. Ann Oncol. 1998. PMID: 9681080 Free article. Clinical Trial.

8

Phase II trial of chemotherapy with 5-fluorouracil, bleomycin, epirubicin, and cisplatin for patients with locally advanced, metastatic, or recurrent undifferentiated carcinoma of the nasopharyngeal type.

Taamma A, Fandi A, Azli N, Wibault P, Chouaki N, Hasbini A, Couteau C, Armand JP, Cvitkovic E. Taamma A, et al. Among authors: fandi a. Cancer. 1999 Oct 1;86(7):1101-8. doi: 10.1002/(sici)1097-0142(19991001)86:7<1101::aid-cncr2>3.0.co;2-r. Cancer. 1999. PMID: 10506692 Clinical Trial.

9

Long-term disease-free survivors in metastatic undifferentiated carcinoma of nasopharyngeal type.

Fandi A, Bachouchi M, Azli N, Taamma A, Boussen H, Wibault P, Eschwege F, Armand JP, Simon J, Cvitkovic E. Fandi A, et al. J Clin Oncol. 2000 Mar;18(6):1324-30. doi: 10.1200/JCO.2000.18.6.1324. J Clin Oncol. 2000. PMID: 10715304

10

Phase I, dose-finding, and pharmacokinetic study of raltitrexed combined with oxaliplatin in patients with advanced cancer.

Fizazi K, Ducreux M, Ruffié P, Bonnay M, Daniel C, Soria JC, Hill C, Fandi A, Poterre M, Smith M, Armand JP. Fizazi K, et al. Among authors: fandi a. J Clin Oncol. 2000 Jun;18(11):2293-300. doi: 10.1200/JCO.2000.18.11.2293. J Clin Oncol. 2000. PMID: 10829050 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

38 results

Search Page

Filters